TP53 and non-small cell lung carcinoma: The lncRNA MEG3 was significantly downregulated in NSCLC tissues, and its overexpression exerted anti-tumour effects, which may induce apoptosis and repress NSCLC development by upregulating the expression of tumour suppressor p53 and activating the p53 pathway [44].